Autoimmune liver disease: evaluating overlapping and cross-over presentations—a case-based discussion
暂无分享,去创建一个
[1] P. Trivedi,et al. Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists , 2015, Hepatology.
[2] K. Lindor,et al. Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. , 2015, Gastroenterology.
[3] M. Taniai,et al. Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.
[4] G. Alexander,et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. , 2013, Gastroenterology.
[5] M. Manns,et al. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. , 2011, Journal of hepatology.
[6] A. Czaja. Autoantibodies as Prognostic Markers in Autoimmune Liver Disease , 2010, Digestive Diseases and Sciences.
[7] Masahiro Ito,et al. Anti‐gp210 and anti‐centromere antibodies are different risk factors for the progression of primary biliary cirrhosis , 2007, Hepatology.
[8] M. Manns,et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.
[9] O. Chazouilleres,et al. Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy , 1998, Hepatology.
[10] A. Czaja. Frequency and nature of the variant syndromes of autoimmune liver disease , 1998, Hepatology.
[11] P. Scheuer,et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. , 1994, Gut.
[12] Lu Lun-ge,et al. Overlap syndromes:the international autoimmune hepatitis group(IAIHG) position statement on a controversial issue , 2011 .
[13] F. Lammert,et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.